Once daily 3g mesalamine is the optimal dose for maintaining clinical remission in ulcerative colitis: A double-blind, double-dummy, randomized, controlled, dose-ranging study

W. Kruis; L. Jonaitis; J. Pokrotnieks; G. Acute; T.L. Mikhailova; M. Horynski; M. Batovsky; I. Racz; K. Kull; M. Faszczyk; R. Greinwald; R. Mueller

doi:10.1016/S0016-5085(08)62285-4

Once daily 3g mesalamine is the optimal dose for maintaining clinical remission in ulcerative colitis: A double-blind, double-dummy, randomized, controlled, dose-ranging study

W. Kruis
, L. Jonaitis
, J. Pokrotnieks
, G. Acute
, T.L. Mikhailova
, M. Horynski
, M. Batovsky
, I. Racz
, K. Kull
, M. Faszczyk
, R. Greinwald
, R. Mueller

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Article number	T1124
Pages (from-to)	A489
Journal	Gastroenterology
Volume	134
Issue number	4, Suppl.1
DOIs	https://doi.org/10.1016/S0016-5085(08)62285-4
Publication status	Published - Apr 2008
Externally published	Yes
Event	Annual Meeting of the American Society for Gastrointestinal Endoscopy (ASGE) "Digestive Disease Week" (DDW 2008) - San Diego, United States Duration: 17 May 2008 → 22 May 2008 https://www.natap.org/2008/DDW/DDW.htm

Field of Science*

3.2 Clinical medicine

Publication Type*

3.3. Publications in conference proceedings indexed in Web of Science and/or Scopus database

Access to Document

10.1016/S0016-5085(08)62285-4

Cite this

Kruis, W., Jonaitis, L., Pokrotnieks, J., Acute, G., Mikhailova, T. L., Horynski, M., Batovsky, M., Racz, I., Kull, K., Faszczyk, M., Greinwald, R., & Mueller, R. (2008). Once daily 3g mesalamine is the optimal dose for maintaining clinical remission in ulcerative colitis: A double-blind, double-dummy, randomized, controlled, dose-ranging study. Gastroenterology, 134(4, Suppl.1), A489. Article T1124. https://doi.org/10.1016/S0016-5085(08)62285-4

@article{0ffda5c9206342a6ba44d23d33d0992c,

title = "Once daily 3g mesalamine is the optimal dose for maintaining clinical remission in ulcerative colitis: A double-blind, double-dummy, randomized, controlled, dose-ranging study",

author = "W. Kruis and L. Jonaitis and J. Pokrotnieks and G. Acute and T.L. Mikhailova and M. Horynski and M. Batovsky and I. Racz and K. Kull and M. Faszczyk and R. Greinwald and R. Mueller",

year = "2008",

month = apr,

doi = "10.1016/S0016-5085(08)62285-4",

language = "English",

volume = "134",

pages = "A489",

journal = "Gastroenterology",

issn = "0016-5085",

publisher = "W.B. Saunders",

number = "4, Suppl.1",

note = "Annual Meeting of the American Society for Gastrointestinal Endoscopy (ASGE) {"}Digestive Disease Week{"} (DDW 2008), DDW 2008 ; Conference date: 17-05-2008 Through 22-05-2008",

url = "https://www.natap.org/2008/DDW/DDW.htm",

}

Kruis, W, Jonaitis, L, Pokrotnieks, J, Acute, G, Mikhailova, TL, Horynski, M, Batovsky, M, Racz, I, Kull, K, Faszczyk, M, Greinwald, R & Mueller, R 2008, 'Once daily 3g mesalamine is the optimal dose for maintaining clinical remission in ulcerative colitis: A double-blind, double-dummy, randomized, controlled, dose-ranging study', Gastroenterology, vol. 134, no. 4, Suppl.1, T1124, pp. A489. https://doi.org/10.1016/S0016-5085(08)62285-4

Once daily 3g mesalamine is the optimal dose for maintaining clinical remission in ulcerative colitis: A double-blind, double-dummy, randomized, controlled, dose-ranging study. / Kruis, W.; Jonaitis, L.; Pokrotnieks, J. et al.
In: Gastroenterology, Vol. 134, No. 4, Suppl.1, T1124, 04.2008, p. A489.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - Once daily 3g mesalamine is the optimal dose for maintaining clinical remission in ulcerative colitis

T2 - Annual Meeting of the American Society for Gastrointestinal Endoscopy (ASGE) "Digestive Disease Week" (DDW 2008)

AU - Kruis, W.

AU - Jonaitis, L.

AU - Pokrotnieks, J.

AU - Acute, G.

AU - Mikhailova, T.L.

AU - Horynski, M.

AU - Batovsky, M.

AU - Racz, I.

AU - Kull, K.

AU - Faszczyk, M.

AU - Greinwald, R.

AU - Mueller, R.

PY - 2008/4

Y1 - 2008/4

UR - https://www-webofscience-com.db.rsu.lv/wos/alldb/full-record/WOS:000255101503433

UR - https://www.sciencedirect.com/science/article/abs/pii/S0016508508622854

U2 - 10.1016/S0016-5085(08)62285-4

DO - 10.1016/S0016-5085(08)62285-4

M3 - Meeting Abstract

SN - 0016-5085

VL - 134

SP - A489

JO - Gastroenterology

JF - Gastroenterology

IS - 4, Suppl.1

M1 - T1124

Y2 - 17 May 2008 through 22 May 2008

ER -

Once daily 3g mesalamine is the optimal dose for maintaining clinical remission in ulcerative colitis: A double-blind, double-dummy, randomized, controlled, dose-ranging study

Field of Science*

Publication Type*

Access to Document

Other files and links

Cite this